PATENT CLAIM ANALYSIS

Application Number: 16201505
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
Provided herein are methods of inhibiting proliferation of one or more tumor cells comprising contacting the one or more tumor cells with a composition comprising one or more epigenetic drugs that inhibit one or more epigenetic mechanisms of the tumor cells, wherein the one or more epigenetic drugs are encapsulated in a nanogel. The invention is also directed to methods of treating a tumor, metastasis of a tumor or a combination thereof in an individual in need thereof. The invention is also directed to a method of sequentially delivering one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell and one or more chemotherapeutic drugs to an individual that has a tumor. Compositions which comprise one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell, wherein the one or more epigenetic drugs are encapsulated in a nanogel.

Claim (Index 4):
The composition of  claim 3  wherein the one or more chemotherapeutic drug is loaded in the nanogel's core and the one or more epigenetic drugs are loaded in the nanogel's corona.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 98.0
- Lexical Diversity: 2.9434
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15011467', '13929981', '15069311', '15427017', '14118224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6749372954641794
- 35 USC 102 Novelty (BERT): 0.5633936345092415
- Combined Prediction Score: 0.6637829293686855
- Mean Citation Score: 233.729464
- Max Citation Score: 443.262
- Similarity Product: 308.21564915513994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test